why choose us

First received: November 11, 2022

Clinical Trial: A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy Subjects

Study Status: Completed

Recruit Status: RECRUITING

Condition: Nonalcoholic Steatohepatitis

Study Type: INTERVENTIONAL


Official Title: A First-in-human, Randomized, Double-blind, Parallel, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of B1344 by Subcutaneous Injection in H

Brief Summary: To evaluate the safety, tolerability, and immunogenicity of B1344 by single subcutaneous (s.c.) injection in healthy subjects

Read more